(Q35190676)

7 August 2017

1 reference

title

Alternative medicines and the liver (English)

1 reference

7 August 2017

Edward Fogden

1

1 reference

7 August 2017

James Neuberger

series ordinal

2

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

23

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

213-220

1 reference

What is complementary medicine?

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

The role of complementary and alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Use of complementary and alternative medicine in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Evaluating complementary medicine: methodological challenges of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Research into complementary and alternative medicine: problems and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Complementary and alternative medicine in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Does use of alternative medicine predict survival from cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Effects of St. John's wort on irinotecan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Survey of alternative medicine use among organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Use of complementary therapies, adherence, and quality of life in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Chaparral-associated hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Liv.52 in alcoholic liver disease: a prospective, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Complementary medicine and the Cochrane Collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Why unconventional medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Recent advances: complementary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Regulation in complementary and alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

ABC of complementary medicine: herbal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

The role of nitric oxide in the inhibition of gastric epithelial proliferation in portal hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Adulterants in Asian patent medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Hydroxyurea in essential thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Contamination of botanical dietary supplements by Digitalis lanata

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Bitter herbs: mainstream, magic, and menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Medical malpractice implications of alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

Traditional remedies and food supplements. A 5-year toxicological study (1991-1995).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Investigating alternative medicine therapies in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

Randomised controlled trials for homoeopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2003.00843.X

7 January 2021

10.1034/J.1600-0676.2003.00843.X

Identifiers

DOI

1 reference

7 August 2017

1 reference